Immunology researchers awarded Novartis Prizes; Rexahn Pharmaceuticals granted patent for new cancer-fighting compounds;

Immunology

> Three scientists have been awarded Novartis Prizes for their groundbreaking research in the field of immunology. Release

Cancer

> Rexahn Pharmaceuticals has been awarded a U.S. patent for new anti-tumor compounds that are inhibitors of an epidermal growth factor receptor (EGFR) often implicated in lung and colon cancer. Release

Rare Diseases

> A rare disease called centronuclear myopathy--which weakens skeletal muscles so severely that children have trouble eating and breathing and often die before age 18--has been identified in dogs, a finding that could help scientists find new ways to diagnose and treat the disorder. Story

Stem Cells

> Nail stem cells may be able to help regrow bones. News

> IntelliCell Bioscienes has been granted a U.S. patent for its stem cell extraction technology to separate stromal vascular fraction cells from adipose (fat) tissue without using enzymes. Release